We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KVSA
226
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $6.59M | 0.09% |
650,112
+16,942
| +3% | +$171K |
|
227
Arcus Biosciences
RCUS
$3.55B
| $6.53M | 0.09% |
357,986
+332,146
| +1,285% | +$6.35M |
|
228
MSC Industrial Direct
MSM
$6.89B
| $6.51M | 0.09% |
77,529
+38,090
| +97% | +$3.16M |
|
229
Amylyx Pharmaceuticals
AMLX
$2.26B
| $6.5M | 0.09% |
221,598
-38,953
| -15% | -$1.35M |
|
230
Zurn Elkay Water Solutions
ZWS
$8.38B
| $6.43M | 0.09% |
301,151
+268,688
| +828% | +$5.91M |
|
|
ALCE
231
DELISTED
Alternus Clean Energy Inc
ALCE
| $6.37M | 0.09% |
24,860
+172
| +0.7% | +$43.8K |
|
232
M&T Bank
MTB
$35.7B
| $6.37M | 0.09% |
53,233
-23,376
| -31% | -$3.39M |
|
233
Prudential Financial
PRU
$42.4B
| $6.36M | 0.09% |
76,907
+73,516
| +2,168% | +$7.02M |
|
|
NFNT
234
DELISTED
Infinite Acquisition Corp.
NFNT
| $6.35M | 0.09% |
609,290
| – | – |
|
235
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $6.34M | 0.09% |
83,176
| – | – |
|
236
iShares Core US Aggregate Bond ETF
AGG
$137B
| $6.27M | 0.09% |
62,950
+53,650
| +577% | +$5.3M |
|
237
Volato Group
SOAR
$7.24M
| $6.26M | 0.09% |
24,008
| – | – |
|
238
Meritage Homes
MTH
$4.58B
| $6.25M | 0.09% |
107,026
+84,110
| +367% | +$4.52M |
|
|
SUAC
239
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
| $6.24M | 0.09% |
600,000
| – | – |
|
240
Carlisle Companies
CSL
$14.6B
| $6.23M | 0.09% |
27,545
-33,276
| -55% | -$8.09M |
|
|
BRD
241
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $6.2M | 0.09% |
597,900
| – | – |
|
242
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $6.15M | 0.09% |
+353,778
| New | +$6.87M |
|
243
Silgan Holdings
SLGN
$4.23B
| $6.12M | 0.08% |
114,116
-43,213
| -27% | -$2.28M |
|
244
Fox Class B
FOX
$21.8B
| $6.11M | 0.08% |
195,037
-251,291
| -56% | -$7.87M |
|
245
PUT
Amazon
AMZN
$2.92T
| $6.08M | 0.08% |
58,900
-116,000
| -66% | -$11.2M |
|
246
Healthpeak Properties
DOC
$15.1B
| $6.08M | 0.08% |
+276,610
| New | +$6.86M |
|
|
ATVI
247
PUT
DELISTED
Activision Blizzard
ATVI
| $6.07M | 0.08% |
70,900
-547,700
| -89% | -$42.5M |
|
248
Ormat Technologies
ORA
$6B
| $6.06M | 0.08% |
+71,516
| New | +$6.27M |
|
249
Lennox International
LII
$14.4B
| $6.04M | 0.08% |
24,023
+22,538
| +1,518% | +$5.69M |
|
250
Pultegroup
PHM
$24.1B
| $5.97M | 0.08% |
102,354
+76,157
| +291% | +$4.11M |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.